C
China Dasheng Biotechnology Co
OTC:CDBT
China Dasheng Biotechnology Co
OTC:CDBT
Price:
0.0424
USD
37.22%
Market Cap:
$1.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
China Dasheng Biotechnology Co
OTC:CDBT
|
US |
|
K
|
Kyungdong Pharm
KOSDAQ:011040
|
KR |
|
M
|
Miraculum SA
WSE:MIR
|
PL |
|
iCollege Ltd
ASX:ICT
|
AU |
|
Western Union Co
NYSE:WU
|
US |
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
CA |
Balance Sheet
Balance Sheet Decomposition
China Dasheng Biotechnology Co
China Dasheng Biotechnology Co
Balance Sheet Decomposition is not available for
China Dasheng Biotechnology Co
China Dasheng Biotechnology Co
Balance Sheet
China Dasheng Biotechnology Co
China Dasheng Biotechnology Co
Currency: USD
| Jun-2008 | ||
|---|---|---|
| Assets | ||
| Cash & Cash Equivalents |
2
|
|
| Cash Equivalents |
2
|
|
| Total Receivables |
5
|
|
| Accounts Receivables |
3
|
|
| Other Receivables |
2
|
|
| Inventory |
1
|
|
| Other Current Assets |
2
|
|
| Total Current Assets |
8
|
|
| PP&E Net |
2
|
|
| PP&E Gross |
2
|
|
| Accumulated Depreciation |
2
|
|
| Intangible Assets |
2
|
|
| Note Receivable |
1
|
|
| Long-Term Investments |
6
|
|
| Other Long-Term Assets |
1
|
|
| Total Assets |
20
N/A
|
|
| Liabilities | ||
| Accounts Payable |
1
|
|
| Accrued Liabilities |
0
|
|
| Short-Term Debt |
0
|
|
| Other Current Liabilities |
0
|
|
| Total Current Liabilities |
2
|
|
| Long-Term Debt |
0
|
|
| Minority Interest |
2
|
|
| Other Liabilities |
1
|
|
| Total Liabilities |
5
N/A
|
|
| Equity | ||
| Common Stock |
0
|
|
| Retained Earnings |
10
|
|
| Additional Paid In Capital |
4
|
|
| Other Equity |
2
|
|
| Total Equity |
16
N/A
|
|
| Total Liabilities & Equity |
20
N/A
|
|
| Shares Outstanding | ||
| Common Shares Outstanding |
30
|
|
Switch to:
Switch to:
See Also
Discover More
